Rocket


Overview
Financials
News + Filings

 
 

4D Molecular Therapeutics Inc Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues14.15.8
            Revenue growth144.0% 
Cost of goods sold24.517.1
Gross profit-10.4-11.3
            Gross margin-73.6%-194.7%
General and administrative6.23.5
EBIT-10.4-11.3
            EBIT margin-73.6%-194.7%
Pre-tax income0.00.0
Income taxes0.00.0
Net income0.00.0
            Net margin0.0%0.0%
 
Diluted EPS$0.00$0.00
Shares outstanding (diluted)5,049.24,953.4
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy